A recent Today Show segment features MSK’s Dr. Helena Yu, discussing successes of targeted lung cancer treatments.

Dr. Helena Yu, right, appearing on the Today Show.

These therapies are discussed in greater depth in a Medpage Today article that quotes MSK’s Dr. Alexander Drilon and an Oncology Nursing News interview with MSK’s Michael D. Offin. Immunotherapy and other new treatments are increasing survival in many patients, often by targeting specific, less-common genetic mutations like BRAF, RET, MET, and NTRK.

A Cancer Network article describes early research by MSK’s Dr. Alison Schram on solid tumors, including lung tumors, with NRG1 gene fusion. Therapy targeting this rare gene fusion in a patient with non-small cell lung cancer reduced the tumor size in the lung and in brain metastases.